In conclusion, Ki67 and Topo IIα may together participate in the occurrence, development and metastasis of breast cancer and joint detection of Topo IIα and Ki67 can provide a better reference for the prediction of the nature, chemotherapeutic efficacy and prognosis of breast cancer. This evidence concerns the gene MKI67 and breast carcinoma.